Cash flow Exelixis, Inc.

Equities

EXEL

US30161Q1040

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 02:30:00 14/02/2026 am IST			5-day change	1st Jan Change
43.92 ^USD	+2.86%		+0.05%	+0.21%

12/02	Biogen Inc. Announces Board Changes	CI
11/02	RBC Raises Price Target on Exelixis to $46 From $45, Keeps Sector Perform Rating	MT

0e72b2952c0f39472cd7f8e9e14a1ec8.n690-JVwlsrxTbAJIfWfVYIn1JSfWSx29JIWTftk9wA.9ZoDksU22Zq_GOZ-e6ymLMZvgdXGGm9ChaFXHb0lrnmn-iGbpyf6vch99Q

Published financial data: EXELIXIS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	143.5Cr	161.11Cr	183.02Cr	216.87Cr	232.01Cr
Total Revenues	143.5Cr	161.11Cr	183.02Cr	216.87Cr	232.01Cr
Cost of Goods Sold, Total	5.29Cr	5.79Cr	7.25Cr	7.62Cr	8.37Cr
Gross Profit	138.21Cr	155.32Cr	175.77Cr	209.25Cr	223.64Cr
Selling General & Admin Expenses, Total	40Cr	46Cr	54Cr	49Cr	52Cr
R&D Expenses	69Cr	89Cr	104.41Cr	91Cr	83Cr
Other Operating Expenses, Total	109.54Cr	135.17Cr	158.68Cr	140.25Cr	134.37Cr
Operating Income	29Cr	20Cr	17Cr	69Cr	89Cr
Interest Expense, Total	-	-	-	-	-
Interest And Investment Income	76.72L	3.31Cr	8.65Cr	7.72Cr	6.92Cr
Net Interest Expenses	76.72L	3.31Cr	8.65Cr	7.72Cr	6.92Cr
Currency Exchange Gains (Loss)	8L	12L	-	-	-
Other Non Operating Income (Expenses)	-10L	-13.97L	93T	-1L	-2L
EBT, Excl. Unusual Items	29Cr	23Cr	26Cr	77Cr	96Cr
Restructuring Charges	-	-	-	-3.37Cr	-2.05Cr
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Asset Writedown	-	-	-	-5.17Cr	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	29Cr	23Cr	26Cr	68Cr	94Cr
Income Tax Expense	6.31Cr	5.21Cr	4.98Cr	16Cr	16Cr
Earnings From Continuing Operations	23Cr	18Cr	21Cr	52Cr	78Cr
Net Income to Company	23Cr	18Cr	21Cr	52Cr	78Cr
Net Income - (IS)	23Cr	18Cr	21Cr	52Cr	78Cr
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	23Cr	18Cr	21Cr	52Cr	78Cr
Net Income to Common Excl. Extra Items	23Cr	18Cr	21Cr	52Cr	78Cr
Per Share Items
Net EPS - Basic	0.73	0.57	0.65	1.8	2.88
Basic EPS - Continuing Operations	0.73	0.57	0.65	1.8	2.88
Basic Weighted Average Shares Outstanding	31Cr	32Cr	32Cr	29Cr	27Cr
Net EPS - Diluted	0.72	0.56	0.65	1.76	2.78
Diluted EPS - Continuing Operations	0.72	0.56	0.65	1.76	2.78
Diluted Weighted Average Shares Outstanding	32Cr	32Cr	32Cr	30Cr	28Cr
Normalized Basic EPS	0.58	0.46	0.51	1.65	2.21
Normalized Diluted EPS	0.57	0.45	0.5	1.62	2.13
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	30Cr	22Cr	20Cr	72Cr	92Cr
EBITA	29Cr	20Cr	17Cr	69Cr	89Cr
EBIT	29Cr	20Cr	17Cr	69Cr	89Cr
EBITDAR	31Cr	24Cr	23Cr	76Cr	95Cr
Total Revenues (As Reported)	143.5Cr	161.11Cr	183.02Cr	216.87Cr	232.01Cr
Effective Tax Rate - (Ratio)	21.45	22.22	19.32	23.53	16.85
Current Domestic Taxes	1.66Cr	11Cr	18Cr	22Cr	3.24Cr
Total Current Taxes	1.66Cr	11Cr	18Cr	22Cr	3.24Cr
Deferred Domestic Taxes	4.65Cr	-6.04Cr	-13Cr	-5.95Cr	13Cr
Total Deferred Taxes	4.65Cr	-6.04Cr	-13Cr	-5.95Cr	13Cr
Normalized Net Income	18Cr	15Cr	16Cr	48Cr	60Cr
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
Advertising Expense	3.18Cr	4.16Cr	4Cr	4.35Cr	5.17Cr
Selling and Marketing Expenses	3.18Cr	4.16Cr	4Cr	4.35Cr	5.17Cr
Research And Development Expense From Footnotes	69Cr	89Cr	104.41Cr	91Cr	83Cr
Net Rental Expense, Total	80.17L	2.14Cr	3.6Cr	3.67Cr	3.19Cr
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., R&D Exp. (Total)	4.67Cr	4.54Cr	3.43Cr	3.07Cr	4.08Cr
Stock-Based Comp., SG&A Exp. (Total)	7.32Cr	6.22Cr	7.2Cr	6.32Cr	7.22Cr
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	12Cr	11Cr	11Cr	9.38Cr	11Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	65Cr	50Cr	26Cr	22Cr	48Cr
Short Term Investments	82Cr	81Cr	73Cr	89Cr	58Cr
Total Cash And Short Term Investments	146.71Cr	130.85Cr	100Cr	111.13Cr	105.91Cr
Accounts Receivable, Total	28Cr	21Cr	24Cr	27Cr	29Cr
Other Receivables	29L	73L	1.31Cr	1.49Cr	1.24Cr
Total Receivables	29Cr	22Cr	25Cr	28Cr	30Cr
Inventory	2.75Cr	3.33Cr	1.73Cr	2.24Cr	2.17Cr
Prepaid Expenses	4.48Cr	5.13Cr	5.48Cr	5.36Cr	6.32Cr
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	98L	36L	-	-	-
Total Current Assets	183.47Cr	161.88Cr	131.8Cr	146.76Cr	144.33Cr
Gross Property Plant And Equipment	19Cr	41Cr	44Cr	39Cr	39Cr
Accumulated Depreciation	-4.08Cr	-6.09Cr	-8.04Cr	-10Cr	-13Cr
Net Property Plant And Equipment	15Cr	35Cr	36Cr	29Cr	26Cr
Long-term Investments	37Cr	76Cr	73Cr	64Cr	60Cr
Goodwill	6.37Cr	6.37Cr	6.37Cr	6.37Cr	6.37Cr
Accounts Receivable Long-Term	16.65L	16.59L	13.21L	4L	-
Deferred Tax Assets Long-Term	11Cr	23Cr	36Cr	42Cr	29Cr
Other Long-Term Assets, Total	8.42Cr	5.41Cr	11Cr	6.68Cr	18Cr
Total Assets	261.62Cr	307.15Cr	294.24Cr	294.77Cr	284.44Cr
Liabilities
Accounts Payable, Total	2.43Cr	3.27Cr	3.38Cr	3.82Cr	2.96Cr
Accrued Expenses, Total	26Cr	21Cr	25Cr	30Cr	28Cr
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	51.37L	1.77Cr	2.57Cr	2.5Cr	2.79Cr
Unearned Revenue Current, Total	78.14L	74.88L	54.06L	27.39L	11.15L
Other Current Liabilities	4.04Cr	5.38Cr	7.73Cr	4.11Cr	6.87Cr
Total Current Liabilities	34Cr	32Cr	39Cr	40Cr	41Cr
Long-Term Leases	5.13Cr	19Cr	19Cr	19Cr	17Cr
Unearned Revenue Non Current	87.39L	65.82L	55.24L	33.92L	61.12L
Other Non Current Liabilities	80.23L	6.2Cr	8.87Cr	11Cr	9.83Cr
Total Liabilities	41Cr	58Cr	68Cr	70Cr	68Cr
Common Stock, Total	3L	3L	3L	3L	3L
Additional Paid In Capital	242.76Cr	253.68Cr	244.07Cr	234.39Cr	223.44Cr
Retained Earnings	-22Cr	-3.42Cr	-17Cr	-9.86Cr	-7.68Cr
Comprehensive Income and Other	-8L	-1.45Cr	-37.5L	-13.47L	34.76L
Total Common Equity	221.06Cr	248.84Cr	226.39Cr	224.42Cr	216.13Cr
Total Equity	221.06Cr	248.84Cr	226.39Cr	224.42Cr	216.13Cr
Total Liabilities And Equity	261.62Cr	307.15Cr	294.24Cr	294.77Cr	284.44Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	32Cr	32Cr	30Cr	28Cr	26Cr
ECS Total Common Shares Outstanding	32Cr	32Cr	30Cr	28Cr	26Cr
Book Value / Share	6.93	7.68	7.48	7.97	8.23
Tangible Book Value	214.69Cr	242.47Cr	220.02Cr	218.05Cr	209.76Cr
Tangible Book Value Per Share	6.73	7.48	7.27	7.74	7.99
Total Debt	5.64Cr	21Cr	22Cr	22Cr	20Cr
Net Debt	-141.07Cr	-110.06Cr	-78Cr	-153.27Cr	-146.18Cr
Debt Equivalent Oper. Leases	6.41Cr	17Cr	29Cr	29Cr	26Cr
Account Code - Inventory Valuation	3	3	3	5	5
Inventories - Raw Materials, Total	-	-	-	-	-
Inventories - Work In Process, Total	-	-	-	-	-
Inventories - Finished Goods, Total	-	-	-	-	-
Inventories - Others	-	-	-	-	-
Machinery, Total	5.44Cr	8.32Cr	9.56Cr	11Cr	12Cr
Full Time Employees	954	1.22T	1.31T	1.15T	1.08T

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	23Cr	18Cr	21Cr	52Cr	78Cr
Depreciation & Amortization - CF	1.36Cr	2.09Cr	2.57Cr	2.88Cr	2.91Cr
Depreciation & Amortization, Total	1.36Cr	2.09Cr	2.57Cr	2.88Cr	2.91Cr
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	11Cr	13Cr	12Cr	1.2Cr
Stock-Based Compensation (CF)	12Cr	11Cr	11Cr	9.38Cr	11Cr
Other Operating Activities, Total	7.53Cr	-4.26Cr	-12Cr	-4.56Cr	14Cr
Change In Accounts Receivable	-12Cr	6.68Cr	-2.26Cr	-2.8Cr	-2.14Cr
Change In Inventories	-1.32Cr	-1.17Cr	-1.3Cr	54.53L	1.22Cr
Change In Accounts Payable	5.51Cr	2.58Cr	5.32Cr	-2.19Cr	-5.02Cr
Change in Unearned Revenues	1.1Cr	-24.83L	-31.4L	-	-
Change in Other Net Operating Assets	3.04Cr	-9.13Cr	-2.85Cr	3.09Cr	-13Cr
Cash from Operations	40Cr	36Cr	33Cr	70Cr	88Cr
Capital Expenditure	-6.42Cr	-2.77Cr	-4.05Cr	-2.84Cr	-84.29L
Sale of Property, Plant, and Equipment	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-11Cr	-12Cr	-3.78Cr	-3.15Cr
Investment in Marketable and Equity Securities, Total	2.13Cr	-39Cr	14Cr	-5.06Cr	39Cr
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-4.29Cr	-52Cr	-2.7Cr	-12Cr	35Cr
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	2.43Cr	2.39Cr	3.34Cr	6.18Cr	4.91Cr
Repurchase of Common Stock	-3.91Cr	-2.33Cr	-58Cr	-69Cr	-101.87Cr
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	-1.48Cr	6L	-55Cr	-63Cr	-97Cr
Net Change in Cash	34Cr	-16Cr	-24Cr	-4.56Cr	27Cr
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	1.3Cr	13Cr	19Cr	17Cr	16Cr
Levered Free Cash Flow	25Cr	15Cr	13Cr	46Cr	63Cr
Unlevered Free Cash Flow	25Cr	15Cr	13Cr	46Cr	63Cr
Change In Net Working Capital	-20.06L	-3.16Cr	-4.95Cr	2.35Cr	2.89Cr
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	7.54	4.43	3.55	14.64	19.27
Return on Total Capital	8.54	5.07	4.13	17.46	23.14
Return On Equity %	11.3	7.76	8.74	23.13	35.53
Return on Common Equity	11.3	7.76	8.74	23.13	35.53
Margin Analysis
Gross Profit Margin %	96.32	96.41	96.04	96.49	96.39
SG&A Margin	27.99	28.54	29.65	22.69	22.36
EBITDA Margin %	20.93	13.8	10.74	33.14	39.73
EBITA Margin %	19.98	12.51	9.34	31.81	38.48
EBIT Margin %	19.98	12.51	9.34	31.81	38.48
Income From Continuing Operations Margin %	16.1	11.31	11.35	24.04	33.73
Net Income Margin %	16.1	11.31	11.35	24.04	33.73
Net Avail. For Common Margin %	16.1	11.31	11.35	24.04	33.73
Normalized Net Income Margin	12.81	9.09	8.79	22.1	25.91
Levered Free Cash Flow Margin	17.45	9.16	6.85	21.41	27.2
Unlevered Free Cash Flow Margin	17.45	9.16	6.85	21.41	27.2
Asset Turnover
Asset Turnover	0.6	0.57	0.61	0.74	0.8
Fixed Assets Turnover	11.06	6.51	5.17	6.63	8.44
Receivables Turnover (Average Receivables)	6.47	6.48	8.09	8.63	8.4
Inventory Turnover (Average Inventory)	2.18	1.91	2.87	3.84	3.8
Short Term Liquidity
Current Ratio	5.43	4.99	3.34	3.63	3.56
Quick Ratio	5.19	4.72	3.16	3.45	3.35
Operating Cash Flow to Current Liabilities	1.19	1.12	0.85	1.73	2.18
Days Sales Outstanding (Average Receivables)	56.41	56.35	45.09	42.43	43.45
Days Outstanding Inventory (Average Inventory)	167.29	191.59	127.35	95.35	96.1
Average Days Payable Outstanding	147.15	163.05	214.32	162.01	149.12
Cash Conversion Cycle (Average Days)	76.54	84.88	-41.89	-24.23	-9.57
Long Term Solvency
Total Debt/Equity	2.55	8.35	9.53	9.62	9.3
Total Debt / Total Capital	2.49	7.71	8.7	8.77	8.51
LT Debt/Equity	2.32	7.64	8.39	8.5	8.01
Long-Term Debt / Total Capital	2.26	7.05	7.66	7.76	7.33
Total Liabilities / Total Assets	15.5	18.98	23.06	23.87	24.02
EBIT / Interest Expense	-	-	-	-	-
EBITDA / Interest Expense	-	-	-	-	-
(EBITDA - Capex) / Interest Expense	-	-	-	-	-
Total Debt / EBITDA	0.18	0.85	0.93	0.29	0.21
Net Debt / EBITDA	-4.58	-4.52	-3.35	-2.03	-1.53
Total Debt / (EBITDA - Capex)	0.23	0.96	1.12	0.3	0.21
Net Debt / (EBITDA - Capex)	-5.78	-5.09	-4.06	-2.11	-1.55
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	45.31	12.27	13.6	18.49	6.98
Gross Profit, 1 Yr. Growth %	45.29	12.38	13.17	19.05	6.88
EBITDA, 1 Yr. Growth %	151.92	-25.95	-11.58	265.59	28.24
EBITA, 1 Yr. Growth %	160.46	-29.71	-15.19	303.75	29.39
EBIT, 1 Yr. Growth %	160.46	-29.71	-15.19	303.75	29.39
Earnings From Cont. Operations, 1 Yr. Growth %	106.71	-21.11	13.98	150.89	50.13
Net Income, 1 Yr. Growth %	106.71	-21.11	13.98	150.89	50.13
Normalized Net Income, 1 Yr. Growth %	124.82	-20.33	9.89	197.83	25.39
Diluted EPS Before Extra, 1 Yr. Growth %	105.71	-22.22	16.07	170.77	57.95
Accounts Receivable, 1 Yr. Growth %	75.7	-24.01	10.53	11.81	8.09
Inventory, 1 Yr. Growth %	31.09	21.12	-47.98	29.24	-3.14
Net Property, Plant and Equip., 1 Yr. Growth %	35.11	131.6	4.79	-19.34	-11.63
Total Assets, 1 Yr. Growth %	22.41	17.4	-4.2	0.18	-3.5
Tangible Book Value, 1 Yr. Growth %	18.26	12.94	-9.26	-0.9	-3.8
Common Equity, 1 Yr. Growth %	17.64	12.57	-9.02	-0.87	-3.69
Cash From Operations, 1 Yr. Growth %	91.79	-9.53	-8.08	110	26.33
Capital Expenditures, 1 Yr. Growth %	111.65	-48.91	46.07	-29.74	-70.36
Levered Free Cash Flow, 1 Yr. Growth %	86.37	-41.08	-15.01	270.2	35.96
Unlevered Free Cash Flow, 1 Yr. Growth %	86.37	-41.08	-15.01	270.2	35.96
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	21.77	27.73	12.94	16.02	12.59
Gross Profit, 2 Yr. CAGR %	21.6	27.78	12.77	16.07	12.8
EBITDA, 2 Yr. CAGR %	-10.85	36.58	-19.09	79.79	116.53
EBITA, 2 Yr. CAGR %	-11.92	35.3	-22.79	85.05	128.56
EBIT, 2 Yr. CAGR %	-11.92	35.3	-22.79	85.05	128.56
Earnings From Cont. Operations, 2 Yr. CAGR %	-15.16	27.7	-5.18	69.11	94.08
Net Income, 2 Yr. CAGR %	-15.16	27.7	-5.18	69.11	94.08
Normalized Net Income, 2 Yr. CAGR %	-14.04	33.83	-6.43	80.91	93.25
Diluted EPS Before Extra, 2 Yr. CAGR %	-15.98	26.49	-4.99	77.28	106.81
Accounts Receivable, 2 Yr. CAGR %	53.39	15.55	-8.35	11.17	9.93
Inventory, 2 Yr. CAGR %	46.07	26	-20.62	-18	11.89
Net Property, Plant and Equip., 2 Yr. CAGR %	28.22	76.89	55.78	-8.07	-15.58
Total Assets, 2 Yr. CAGR %	17.79	19.88	6.05	-2.04	-1.68
Tangible Book Value, 2 Yr. CAGR %	15.04	15.57	1.23	-5.17	-2.36
Common Equity, 2 Yr. CAGR %	14.51	15.08	1.2	-5.03	-2.29
Cash From Operations, 2 Yr. CAGR %	-12.79	31.72	-8.81	38.94	62.88
Capital Expenditures, 2 Yr. CAGR %	123.7	-4.45	-13.61	1.31	-54.36
Levered Free Cash Flow, 2 Yr. CAGR %	-17.7	4.79	-29.23	77.38	124.35
Unlevered Free Cash Flow, 2 Yr. CAGR %	-17.7	4.79	-29.23	77.38	124.35
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	18.89	18.52	22.83	14.76	12.93
Gross Profit, 3 Yr. CAGR %	18.6	18.45	22.71	14.83	12.92
EBITDA, 3 Yr. CAGR %	-12.28	-16.2	18.15	33.77	60.64
EBITA, 3 Yr. CAGR %	-13.31	-18.3	15.8	34.01	64.24
EBIT, 3 Yr. CAGR %	-13.31	-18.3	15.8	34.01	64.24
Earnings From Cont. Operations, 3 Yr. CAGR %	-30.56	-17.19	22.95	31.15	62.53
Net Income, 3 Yr. CAGR %	-30.56	-17.19	22.95	31.15	62.53
Normalized Net Income, 3 Yr. CAGR %	-13.42	-16.19	25.32	37.64	60.1
Diluted EPS Before Extra, 3 Yr. CAGR %	-31.19	-18.12	22.92	34.71	70.59
Accounts Receivable, 3 Yr. CAGR %	20.2	21.37	13.85	-2.07	10.13
Inventory, 3 Yr. CAGR %	40.85	37.23	-6.17	-6.62	-13.32
Net Property, Plant and Equip., 3 Yr. CAGR %	37.99	56.15	48.56	25.09	-9.27
Total Assets, 3 Yr. CAGR %	22.53	17.66	11.24	4.06	-2.53
Tangible Book Value, 3 Yr. CAGR %	20.61	14.34	6.62	0.52	-4.72
Common Equity, 3 Yr. CAGR %	19.75	13.86	6.41	0.5	-4.59
Cash From Operations, 3 Yr. CAGR %	-1.21	-11.71	16.84	20.42	34.6
Capital Expenditures, 3 Yr. CAGR %	24.48	29.24	10.07	-19.36	-32.74
Levered Free Cash Flow, 3 Yr. CAGR %	12.76	-26.37	-2.27	22.85	62.33
Unlevered Free Cash Flow, 3 Yr. CAGR %	12.76	-26.37	-2.27	22.85	62.33
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	49.61	28.91	16.47	17.51	18.63
Gross Profit, 5 Yr. CAGR %	49.45	28.77	16.23	17.49	18.65
EBITDA, 5 Yr. CAGR %	63.49	5.73	-15.07	13.73	50.55
EBITA, 5 Yr. CAGR %	60.75	3.81	-17.23	13.3	51.99
EBIT, 5 Yr. CAGR %	60.75	3.81	-17.23	13.3	51.99
Earnings From Cont. Operations, 5 Yr. CAGR %	26.9	3.4	-21.34	10.18	47.58
Net Income, 5 Yr. CAGR %	26.9	3.4	-21.34	10.18	47.58
Normalized Net Income, 5 Yr. CAGR %	38.65	7.96	-10.69	14.01	49.03
Diluted EPS Before Extra, 5 Yr. CAGR %	20.77	2.57	-21.71	11.53	51.35
Accounts Receivable, 5 Yr. CAGR %	47.53	22.68	7.84	17.18	12.27
Inventory, 5 Yr. CAGR %	52.46	37.98	11.98	11.68	0.67
Net Property, Plant and Equip., 5 Yr. CAGR %	135.23	68.09	44.85	26.33	18.5
Total Assets, 5 Yr. CAGR %	34.44	36.2	15.65	9.35	5.88
Tangible Book Value, 5 Yr. CAGR %	142.44	61.42	12.45	6.09	2.93
Common Equity, 5 Yr. CAGR %	89.98	54.25	11.95	5.89	2.84
Cash From Operations, 5 Yr. CAGR %	13.76	16.97	-4.32	5.84	33.44
Capital Expenditures, 5 Yr. CAGR %	106.68	5.56	3.98	17.25	-22.6
Levered Free Cash Flow, 5 Yr. CAGR %	73.65	9.84	-6.41	4.66	36.26
Unlevered Free Cash Flow, 5 Yr. CAGR %	133.25	8.59	-6.41	4.66	36.26